For more information about upcoming webinars, please see the ACT Education page!
The Accelerating Clinical Trials (ACT) Consortium recently held a competition for ACT Network members to support innovative knowledge mobilization practices. Knowledge mobilization is a key
The Accelerating Clinical Trials (ACT) Consortium recently held a competition to bring high-impact randomized controlled trials to Canada that were initiated and are led by
International review panel selects CanReview to set up, initiate, and conduct a pan-Canadian single REB review and approval process with strict timelines. The Accelerating Clinical
Click here for a full summary of the ACT October Meeting In preparation for the Third ACT Consortium Meeting, we are seeking Canadian biotechnology companies
New pan-Canadian data and sample transfer agreement a game-changer for clinical research “We’ve built a high-speed legal highway for researchers to use to share their
For more information about upcoming webinars, please see the ACT Education page!
The Accelerating Clinical Trials Consortium is generously supported through multi-year funding from the Canadian Institutes of Health Research’s Clinical Trials Fund, as part of Canada’s Biomanufacturing and Life Sciences Strategy to ensure that Canadians are well served by a national clinical trials network.